in yeast SC formation 25 but suggests that they are not essential for SC stability, which is similar to findings in mammalian systems. The high resolution of the map allowed the confident modeling of 96% of all amino acids in the structure ( Table 1 ). All prosthetic groups and metal cofactors are well defined and 44 lipids including eight cardiolipin molecules can be confidently modeled.
Atomic resolution structure of the S. cerevisae CIV. The yeast CIV structure comprises 12 subunits ( Fig. 2a and Supplementary   Table 1 ). Cox1-3 form the catalytic core and are surrounded by nine supernumerary subunits (Cox4-9, Cox12, Cox13, Cox26). The structure of yeast CIV is remarkably similar to mammalian systems, with a calculated root mean squared deviation against bovine 26 and human 16 enzymes of 0.95 and 1.10 Å, respectively, but there are notable differences as discussed below. Subunit composition is also very similar: all but one S. cerevisiae subunit (Cox26) have homologs in mammals and conversely, all mammalian subunits but three (COX7B, COX8 and NDUFA4) have yeast homologs. Yeast Cox5 (homologous to mammalian COX4) exists as one of two isoforms depending on oxygen level 27 . In normoxic conditions, almost all CIV is assembled with the Cox5A isoform, although low levels of Cox5B are also expressed. To enhance the homogeneity of our protein preparations, we used a COX5B knockout mutant strain (ΔCOX5B) that only expresses the Cox5A isoform.
Cox1 and Cox2 house the prosthetic groups responsible for electron transfer and O 2 reduction, namely the dinuclear Cu A center, heme a, heme a 3 and Cu B . All prosthetic groups are well resolved in the EM map, as well as the characteristic HPEVY ring of amino acids formed by covalent linkage between Nε 2 -His241 and Cε -Tyr245 in Cox1 ( Supplementary Fig. 3 ). Clear densities were observed at the expected magnesium and calcium/sodium binding sites in Cox1 (modeled as a Ca 2+ ion 28 ) and the zinc binding site in Cox4. The density map also confirms the predicted positioning of the residues forming the D-, K-and H-channels described as putative proton pathways in Cox1 of A1-type oxidases 29 .
Cox26, recently assigned as a subunit of S. cerevisiae CIV 23, 24 , is composed of a single transmembrane helix with a kink towards its C terminus. This arrangement enables extensive hydrophobic interactions with Cox1 and Cox2 (Fig. 2b) , which are further supported by two lipids held against the core of the enzyme. In the matrix, Cox26 interacts at its N terminus with Cox6 and Cox9 via a network of electrostatic and hydrophobic interactions (Fig. 2b) . Deletion of Cox26 does not prevent CIV assembly, nor does it have any notable effect on its activity 23, 24 . However, the position of Cox26 in the SC, and the interactions it makes with the subunits above, suggest Cox26 could stabilize the region of CIV at the interface with CIII, supporting a role in formation or stability of the III 2 IV 2 SC, even though no direct connection with CIII is evident from the structure.
A notable difference between yeast and mammalian CIV is the conformation of the N-terminal domain of Cox5A ( Fig. 2c ) that is shifted towards CIII in the S. cerevisiae SC to form protein-protein interactions further described below. This region is implicated in allosteric inhibition of CIV by ATP [30] [31] [32] and Ser43, a residue that was shown by mutagenesis to contribute to this allosteric effect 32 , is at the interface with CIII. More detailed biochemical analyses will be required to determine whether SC formation has a role in the ATP feedback inhibition mechanism. Another difference is seen in Cox13, the most peripheral subunit of the SC (Figs. 1c and 2a,d). Cox13 is characterized by a single extended and bow-shaped transmembrane α -helix, protruding from the membrane into the matrix and the intermembrane space (IMS), with a π bulge between residues Ser55 and Leu60. The N and C termini of Cox13 are oriented towards the core of the complex, interacting with Cox1 and Cox3 on the IMS and Cox4 on the matrix side. Its mammalian homolog, COX6A, has a shorter N terminus that folds back into the membrane, providing the dimerization interface observed in the bovine crystal structure (Fig. 2d ). The relevance of the dimeric state of CIV is still disputed, and refinement of CIV within the human respirasome 16 showed that NDUFA4 would prevent dimerization via COX6A. Yeast does not have a NDUFA4 homolog but the peculiar arrangement of Cox13 observed here in the yeast SC would hinder CIV dimerization via this subunit.
Complete structure of S. cerevisiae CIII. In S. cerevisiae, each CIII monomer consists of 10 subunits. Cytochrome b, cytochrome c 1 and Rip1 form the catalytic core containing two hemes B, one heme C and a [2Fe-2S] cluster, respectively. All prosthetic groups are visible in the density map along with a molecule of ubiquinone in two apparent configurations at the Q i site residing between the two cytochrome b subunits ( Supplementary Fig. 4 and Fig. 3a ). This is a common feature in structures of CIII of various origins, including yeast, whenever the hydrophobic substrate was not completely extracted from the preparation, and it is due to the higher affinity of ubiquinone to the Qi site as compared to Qo. Apart from the presence of Qcr10 and changes resulting from interactions with CIV (see below), our model is consistent with the CIII structures described previously 33 .
Despite low sequence identity, the transmembrane helix of Qcr10 ( Fig. 3a , pink ribbon) occupies a position similar to that of subunit 11 in mammalian structures 34 , making extensive interactions with Qcr9 and with Rip1 on the IMS side of the inner mitochondrial membrane supported by a lipid (Fig. 3a,b ). In the matrix, the extended N terminus of Qcr10 interacts with Cor2 and Qcr7 of the other monomer ( Fig. 3c ), while in the IMS, Qcr10 extends to interact with cytochrome c 1 (Fig. 3d ). These observations are in line with the proposed role of Qcr10 in CIII assembly and Rip1 stability 35 .
A conformational change is observed at the N terminus of the transmembrane helix of Rip1 due to interactions with a cardiolipin molecule that also interacts with Cox5A ( Fig. 3e and below) suggesting SC formation could have a role in stabilizing this part of CIII. However, this change at the N terminus does not seem to impact the head domain of Rip1, which maintains its known flexibility. 
Fig. 3 | interactions of Qcr10 with other subunits of Ciii, and that of Rip1
with a lipid at the interface with CiV. a, Position of Qcr10 (pink ribbon) in the CIII structure with its N and C termini highlighted. Other subunits of CIII that interact with Qcr10 are highlighted in colors. A molecule of ubiquinone at the Qi site is shown as blue spheres. The boxes indicate specific regions of interaction that are highlighted in the other panels. b, Qcr10 (pink) forms interactions with the transmembrane helix of Rip1 (yellow) and with Qcr9 (green) at both the matrix and IMS faces of the membrane. c, The N-terminal tail of Qcr10 interacts with Cor2 (purple) and Qcr7 (cyan) in the matrix. d, Interactions in the IMS between Qcr10 and Cytc 1 (gray), Rip1 (yellow) and Qcr9 (green). e, A slight shift in the N terminus of Rip1 (yellow) compared to the yeast X-ray structure (blue) accommodates interactions with a cardiolipin that goes on to interact with Cox5A of CIV (light pink), forming part of the interface between the two complexes.
The CIII-CIV interface. While the CIII dimer is symmetrical and no differences can be seen in the two CIII-CIV interfaces, the alignment of the two halves of the merged SC structure on CIII reveals a deviation of up to 3 Å at the extreme periphery of CIV ( Supplementary Fig. 5 ). This most probably arises from the intrinsic flexibility of the SC and explains why a 3D refinement with C2 symmetry failed to improve the SC resolution (see Methods).
The CIII-CIV interface reveals protein-protein interactions on either side of the inner mitochondrial membrane and interactions via bridging lipids in the membrane region itself. The majority of interactions occur on the matrix side between Cor1 and the N terminus of Cox5A, facilitated by the conformational shift in the latter as described above (Fig. 4a ). In the IMS, the C-terminal domain of Cox5A is in position to interact with both the C terminus of Qcr6 and a loop region between helices 6 and 7 of cytochrome c 1 (Fig. 4b,c ). Within the membrane, Cox5A contacts the N-terminal helix of Rip1 and Qcr8 via a cardiolipin molecule and another lipid modeled as phosphocholine ( Fig. 4d ). Two other cardiolipins indirectly support the CIII-CIV interface highlighting their crucial role in SC formation 36 .
Previous work indicates that mammalian COX7A2L is required for the formation and stability of the CIII-CIV SC in mammals 37 , which is consistent with published respirasome structures 11, 12 . S. cerevisiae has no homolog of COX7A2L so it must follow a different mechanism of CIII-CIV SC formation than the one proposed in mammals. In addition, our work suggests that the III 2 IV 2 SC in yeast doesn't require any other proteins to maintain its stability, the interaction between Cox5A and Cor1, two highly conserved subunits and phospholipids being sufficient to stabilize the SC. However, no mammalian structure of the III 2 IV 1/2 SC is currently available and, in the absence of CI, it cannot be excluded that the CIII-CIV interface is different in a III 2 IV 1/2 SC compared to the respirasome. Mammalian CIV has an additional subunit, COX7B, in front of COX4-1 (the mammalian homolog of Cox5A). However, superimposition of the bovine CIV structure onto the yeast III 2 IV 2 SC suggests a similar interaction between CIII and CIV as the one observed in yeast remains possible ( Supplementary Fig. 6 ).
Discussion
The functional role of SC formation is still unclear 38, 39 . Reactive oxygen species prevention by steric inhibition of one half of CIII by CIV in the respirasome has been proposed 40 . In the yeast III 2 IV 2 SC, the symmetry of CIII is maintained and no obvious interactions are apparent that could stabilize the hinge region of Rip1, whose flexibility allows the movement of the head group domain, which is implicated in reactive oxygen species production. However, it is noteworthy that the same subunits of CIII are involved in SC formation in all SC structures resolved so far (Fig. 5 ). The homologs of yeast CIII subunits Cor1, Rip1, Qcr6 and Qcr8 interact with CI in the mammalian respirasome structures. These are the same subunits that interact with CIV in our III 2 IV 2 structure, highlighting a conservation of the CIII interaction interface, albeit one occupied by CI in mammals and by CIV in S. cerevisiae, which lacks CI. Additionally, in the CI-containing Yarrowia lipolytica
Lys97 CDL PCF respirasome, where the CIII symmetry is apparently maintained, the suggested CIII-CIV arrangement is similar to the one observed in the yeast III 2 IV 2 SC 6 . This suggests that SC formation may serve to stabilize the active CIII monomer(s) by other proteins. Finally, modulation of CIV activity in response to energy requirements by differential expression of isoforms such as Cox5 in yeast 41 (COX4 in mammals 4 ) and COX7A in mammals 42 has been recognized. From the yeast structure presented here and that of mammalian respirasomes, it seems that these subunits form a substantial part of the interface between proteins in SCs. Therefore, biochemical and biophysical studies investigating these isoforms, and the effect of allosteric sites identified within supernumerary subunits on CIV core catalytic subunits, must take into account SC formation. With homologs of many mammalian supernumerary subunits, extensive genetic amenability and in light of the SC structures now available, S. cerevisiae offers a powerful system to study how these factors modulate CIV activity and respiratory SC formation.
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Methods
Yeast strain and cell growth. A Δ COX5B S. cerevisiae strain only expressing the Cox5A isoform of CIV (α ade2 leu2 trp1 ura3 cox5B::KanMx4) with a six-histidinetag at the C terminus of COX13 was constructed from W303-1B 43, 44 . Yeast cells were grown in YPGal (1% yeast extract, 2% peptone and 2% galactose) medium at 28 °C in 2 l baffled flasks with shaking at 200 r.p.m. as described in Meunier et al. 43 . Cells were harvested in late log phase by centrifugation at 6,500 r.p.m. for 5 min at 4 °C. Cells were washed by resuspension in 50 mM KPi, pH 7.0 and centrifuged again. Cell pellets were stored at − 80 ˚C until use.
Preparation of mitochondrial membranes. Mitochondrial membranes were prepared essentially as described previously 43 . Briefly, thawed yeast cells were resuspended in 30 ml 650 mM D-mannitol, 50 mM KPi, 5 mM EDTA, pH 7.4 containing 0.1 mM phenylmethylsulfonyl fluoride (PMSF). Glass beads (425-600 μ m diameter) were added and cells were broken by mechanical lysis using a bead-beater cell disruptor. Cell debris was removed by centrifugation at 5,600g for 20 min at 4 °C, and the supernatant was centrifuged at 120,000g for 50 min at 4 °C to harvest the mitochondrial membranes. The membranes were then resuspended and homogenized in 50 mM KPi, 100 mM KCl, 10 mM Analytical methods. Resulting fractions were then concentrated and analyzed for heme content and purity using UV-visible difference spectroscopy and BN-PAGE.
Final protein concentration was determined by the Pierce bicinchoninic acid protein assay (Thermo Scientific) as per the manufacturer's protocol.
UV-visible difference spectroscopy. UV-visible difference spectra were recorded between 400 and 700 nm using a home built spectrophotometer. Protein samples were diluted as necessary in 50 mM HEPES, 0.1% N-undecyl-β -dmaltoside (UDM) and pH 8.0. Spectra were measured from sodium dithionite reduced minus oxidized spectra, using absorption coefficients (Δ Ɛ ) of 26 mM −1 cm −1 (604-621 nm) and 28 mM −1 cm −1 (562-578 nm) for CIV and CIII, respectively. Schägger 45 until the entire amount of protein entered into the gel (~30 min, 50 V). A molecular mass marker (precision plus protein standards, dual color, BioRad) was used to monitor the correct loading of proteins into the gel. Gel-spots containing SC III 2 IV 2 were cut and prepared for mass spectroscopy identification, following the in-gel trypsin digestion protocol described previously 46 . Tryptic peptides were separated by liquid chromatography and analyzed by tandem mass spectroscopy in a Q-Exactive 2.0 Orbitrap Mass Spectrometer equipped with an Easy nLC1000 nano-flow ultra-high-pressure liquid chromatography system (Thermo Fisher Scientific). The mass spectrometer was run twice for each sample. Mass spectroscopy raw data files were analyzed using the MaxQuant software (v.1.5.0.25) using the settings detailed in Guerrero-Castillo et al. 47 , except for the search against a compiled version of the S. cerevisiae protein database including the pig trypsin and other protein contaminants, such as human keratins.
Activity measurements. Steady-state oxygen consumption rates were measured using a Clark-type oxygen electrode (Oxygraph, Hansatech), operated at 25 °C. Assays were conducted with purified protein at 15 nM, in 10 mM KPi, 50 mM KCl and pH 6. Cryo-electron microscopy. Purified III 2 IV 2 SC (9 mg ml −1 total protein) was diluted 1:3 in 50 mM HEPES, 150 mM NaCl, 0.05% GDN and pH 7.2 and applied to glow discharged UltrAuFoil R1.2/1.3 grids (Quantifoil). Grids were blotted for 8.5 s at 4 °C and 100% humidity, and then rapidly frozen in liquid ethane using a Vitrobot Mark IV (Thermo Fisher) and stored in liquid nitrogen. Preliminary imaging was done using a Polara microscope operated at 300 kV and equipped with a Quantum energy filter (Gatan) with a post-GIF K2 Summit direct electron detector (Gatan) operating in counting mode. The primary data were collected using a Titan Krios microscope (Thermo Fisher) operated at 300 kV and equipped with a Quantum energy filter (Gatan) (electron Bio-Imaging Center, Diamond Light Source). The images were collected with a post-GIF K2 Summit direct electron detector (Gatan) operating in counting mode at a nominal magnification of × 130,000, corresponding to the pixel size of 1.048 Å. An energy slit with a width of 20 eV was used during data collection. The dose rate on the specimen was set to 6.58 electrons per Å 2 per s and a total dose of 52.64e per Å 2 was fractionated over 32 frames. Data were collected using EPU software (Thermo Fisher) with a nominal defocus range set from − 1.6 μ m to − 3.6 μ m. A total of 2,740 micrographs were collected.
Image processing. Frame alignment and exposure weighting were performed with MOTIONCOR2 48 . Contrast transfer function parameters of the motioncorrected micrographs were estimated with CTFFIND4.1 49 . Micrographs were screened manually to remove those with excessive specimen drift, overfocus or ice defects. 98,968 particles were selected from the 2,634 remaining micrographs using reference-free particle picking with Gautomatch v.0.53 (written by K. Zhang, https://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch/), using a 360 × 360 Å 2 box size. Particles were sorted using several iterations of reference-free twodimensional classification in cryoSPARC 50 , resulting in a final particle number of 52,257. An initial model was build using ab initio reconstruction in cryoSPARC, which was refined using heterogeneous refinement in RELION v.3.0 51 . The III 2 IV 2 SC accounted for 44,915 (86%) of the particles present (14% represented the III 2 IV 1 SC) and these particles were then used for homogeneous refinement in RELION v.3.0 resulting in a 3.31 Å resolution map, based on the FSC-gold standard. Local resolution was calculated using ResMap 52 , revealing a range of resolutions in the map, with the core of CIII resolved to 2.9-3.2 Å, whereas the peripheral edges of the two CIV proteins were resolved to 5-8 Å.
To increase the resolution of the two CIV monomers, we used a particle subtraction approach 20 . In short, a soft mask was generated around III 2 IV b and used to subtract density from the particles, resulting in a new set of particles that was used for focussed 3D refinement of CIVa. This process was repeated with a soft mask around III 2 IV a to refine CIVb. This resulted in an increased resolution of the two CIV monomers to 3.31 Å and 3.38 Å, with a homogeneous distribution of resolution throughout the protein ( Supplementary Fig. 2 ). The two CIV maps were then aligned to the original map of the SC and a merged map was generated using UCSF Chimera 53 .
Model building. The three individual maps described above were used for all model building using real space refinement (Table 1) in Coot 54 . A high-resolution crystal structure of dimeric CIII (PDB 1KYO) 55 and a yeast homology model 22 were used as starting references for model building. All maps displayed clearly interpretable features such as bulky side chains, metal clusters, heme ligands, cardiolipin and ubiquinone. These features enabled unambiguous assignment of amino acids in all chains, except some flexible N and C termini. Notably, the C terminus of Rip1 of CIII has weak density (residues 95-215), and this is attributed to its characteristic flexibility. Its Fe-S cluster is clearly visible in the map. Finally, the N-terminal residues of Qcr6 (1-73) in CIII, are not resolved, a feature common to all yeast CIII crystal structures, possibly due to the high composition of charged residues in this region. Additional densities in the map indicated the presence of long carbon chains that were modeled as di-palmitoyl-phosphatidylethanolamine (PEF), diacyl-glycero-phosphocholine (PCF) and cardiolipin (CDL) molecules on the basis of map interpretation and similarities with previous structures where these ligands were found. Lipid tails were truncated according to the density maps. The three models (dimeric CIII and two CIV monomers) where then individually refined using the real space refine tool in Phenix 56 , using secondary structure restraints. Geometry definitions for the ligands were defined from values in the CCP4 ligand library 57 . Additional bond and distance restraints were implemented on specific molecules on the basis of previously published highresolution structures. For initial refinement in Phenix, Ramachandran and rotamer constraints were also used. The models were then visually inspected in Coot for additional corrections. A final real space refinement was performed in Phenix by disabling rotamer constrains resulting in an increase of the model-to-map fit. To confirm the validity of the map, a final real space refinement was performed to the complete III 2 IV 2 SC using the merged map described above. The final model contains 7,636 protein residues and 69 ligands. For the CIII dimer we modeled 4 B-hemes and 1 ubiquinone molecule in the 2 cytochrome b subunits, 1 C-heme for each cytochrome c 1 A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
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Sample size
No statistical methods were used to predetermine sample size Data exclusions A fraction of the acquired cryo-EM movies were discarded because of excessive specimen drift, overfocus or ice defects.
Replication
Sample preparation at the quality for cryo-EM specimen preparation was repeated three times and final UV/visible difference spectra, gel filtration elution profile and BNPAGE gels were obtained in each case. Activity measurements were performed in duplicate on two of these preparations. Cryo-EM data collection and structure calculation were not repeated.
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